Tag: AI drug design
AI minibinders bind PD-L1 but falter on other cancer targets
New screens show AI-designed minibinders hit PD-L1 but struggle on other cancer targets.
New screens show AI-designed minibinders hit PD-L1 but struggle on other cancer targets.